Daniel Janney
Director at Krystal Biotech, Inc. (KRYS)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $19.4M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Mar 3SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 9,43075,666 held (−11%) | $275.45 | $2.6M | +20.4% |
| Mar 3SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 2,37373,293 held (−3%) | $276.17 | $655K | +20.1% |
| Feb 26SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 56937,326 held (−2%) | $262.91 | $150K | +26.1% |
| Feb 26SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 1,73335,593 held (−5%) | $264.12 | $458K | +25.6% |
| Feb 26SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 3,55732,036 held (−10%) | $265.08 | $943K | +25.1% |
| Feb 26SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 8,98623,050 held (−28%) | $266.18 | $2.4M | +24.6% |
| Feb 26SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 11,67311,377 held (−51%) | $266.97 | $3.1M | +24.2% |
| Feb 26SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 6,6714,706 held (−59%) | $268.04 | $1.8M | +23.7% |
| Feb 26SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 3,963743 held (−84%) | $268.97 | $1.1M | +23.3% |
| Feb 26SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 370373 held (−50%) | $269.83 | $100K | +22.9% |
| Feb 26SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 373 | $271.09 | $101K | +22.3% |
| Feb 26SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 62107,300 held (−0%) | $263.05 | $16K | +26.1% |
| Feb 26SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 900106,400 held (−1%) | $264.60 | $238K | +25.3% |
| Feb 26SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 1,604104,796 held (−2%) | $265.54 | $426K | +24.9% |
| Feb 26SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 4,339100,457 held (−4%) | $266.62 | $1.2M | +24.4% |
| Feb 26SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 1,89198,566 held (−2%) | $267.37 | $506K | +24.0% |
| Feb 26SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 1,67496,892 held (−2%) | $268.67 | $450K | +23.4% |
| Feb 26SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 93095,962 held (−1%) | $269.50 | $251K | +23.0% |
| Feb 26SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 2,42593,537 held (−3%) | $274.90 | $667K | +20.6% |
| Feb 26SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 70092,837 held (−1%) | $275.00 | $192K | +20.6% |
| Feb 26SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 5,10387,734 held (−5%) | $275.28 | $1.4M | +20.5% |
| Feb 26SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 2,63885,096 held (−3%) | $276.32 | $729K | +20.0% |
- Sell
Director Daniel Janney sold $2.6M of KRYS at $275.45 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Daniel Janney sold $655K of KRYS at $276.17 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Daniel Janney sold $150K of KRYS at $262.91 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Daniel Janney sold $458K of KRYS at $264.12 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Daniel Janney sold $943K of KRYS at $265.08 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Daniel Janney sold $2.4M of KRYS at $266.18 — cuts the stake by 28%; pre-scheduled 10b5-1 plan sale.